Gallein and isoniazid act synergistically to attenuate Mycobacterium tuberculosis growth in human macrophages.
Ontology highlight
ABSTRACT: Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis (TB), can be difficult to treat because of drug resistance. Increased intracellular polyphosphate (polyP) in Mtb enhances resistance to antibiotics, and capsular polyP in Neisseria gonorrhoeae potentiates resistance to antimicrobials. The mechanism by which bacteria utilize polyP to adapt to antimicrobial pressure is not known. In this study, we found that Mtb adapts to the TB frontline antibiotic isoniazid (INH) by enhancing the accumulation of cellular, extracellular, and cell surface polyP. Gallein, a broad-spectrum inhibitor of the polyphosphate kinase that synthesizes polyP, prevents this INH-induced increase in extracellular and cell surface polyP levels. Gallein and INH work s
SUBMITTER: Rijal R
PROVIDER: S-EPMC10802476 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA